Abstract:In the realm of arterial disease interventions, drug-eluting stents (DES) have become a vital therapeutic choice in preventing atherosclerotic plaque formation and restenosis and facilitating vessel healing. Sirolimus-encapsulated poly Lactic-co-Glycolic acid (PLGA) Microparticles (MPs) were developed using solvent evaporation. MPs were freeze-dried with a cryoprotectant and coated on the stent surface using an efficient and reproducible nitrogen-assisted spray coating technique. The MPs displayed a uniform distribution particle size of 4.38 ± 1.1 μm, span value of 0.88 ± 0.02, coating mass transfer efficiency of 13.45 ± 1.1 % on the stent, and a coating time of ≤ 2 min per stent. Post sterilization, the particle size and morphology of the coated stents remained unchanged. Accelerated in vitro drug release profiles were evaluated under different conditions, indicating significant influences based on dissolution methods ranging from 28.2 %±4.3 %, 42.5 %±5.3 %, 76.6 %±4.7 %, and 84.25 %±3.1 % for dialysis bag (DB), vessel simulating flow-through cell (vFTC), flow-through cell (FTC), and sample and separate (SS) technique respectively for 48 h. The drug release mechanism from the coated stents is governed by the combination of the Korsmeyer Peppas and Higuchi models. The developed dissolution method exhibited discriminative effectiveness when evaluated with critical formulation attributes and process parameter variations. The 48 h accelerated drug release studies correlated well with the 6-month real-time release rate with an R2 value of 0.9142 and Pearson's R2 of 0.9561. Ex-vivo studies demonstrated the permeation of MPs into artery tissues. Stability studies confirmed that MPs coated stents maintained desired properties at 4 °C and 30 °C/65 % RH for 6 months. Overall, these findings contribute to advancing stent technology, suggesting the potential for improvement of arterial interventions and enhanced patient outcomes.

Effect of Preparation Methods on Property and Drug Release Kinetics of Sirolimus Loaded Poly (ethylene Carbonate) Coatings

Influence of Preparation Methods on Structure and in Vitro Drug Release Kinetics of Drug-Loading Coating

Preparation of 3,4-Dihydroxy-L-phenylalanine modified organic-inorganic hybrid coatings for drug eluting stents

Preparation and in Vitro Release Profiles of Drug-Eluting Controlled Biodegradable Polymer Coating Stents

Preparation and Characterization of Drug Contained Ethylene-Vinyl Alcohol Copolymer Coatings on 316L Stainless Steel

Preparation and Properties of Drug-Loaded Coating on Biodegradable Magnesium Alloy

In Vitro Release Study of Sirolimus from a PDLLA Matrix on a Bioresorbable Drug-Eluting Stent

Drug Release Kinetics from a Drug-Eluting Stent with Asymmetrical Coat.

Drug-Eluting Coronary Stents Coated with Polysulfone-Poly(ethylene Oxide) Block Copolymer by Ultrasonic Spray

Controlled release of aspirin from SiO2-PEG hybrid coating on 316Lss substrate for the preparation of drug eluting stents

The Effect of Fluid Shear Stress on the In Vitro Release Kinetics of Sirolimus from PLGA Films

Preparation and performance of coronary stent PLGA coating using electrospray deposition(ESD)

Coating for dexamethasone-eluting intravascular stent and its drug sustained release in vitro

In vitro drug release profiling of Sirolimus polymeric microparticles coated long-acting stents

Evaluation of Two Polymeric Blends (EVA/PLA and EVA/PEG) As Coating Film Materials for Paclitaxel-Eluting Stent Application

Preparation and Drug Release of Dual Controlled Coatings on Magnesium Alloys Stent

Investigation on biological properties of tacrolimus-loaded poly(1,3-trimethylene carbonate) in vitro

Design and Testing of Hydrophobic Core/hydrophilic Shell Nano/micro Particles for Drug-Eluting Stent Coating

Drug loading strategies and applications of drug eluting stents

Study on tacrolimus-loaded poly(1, 3-trimethylene carbonate) as drug-eluting stent coating

Research Progress in Drug-loaded Coating Materials of Drug Eluting Stents and Their Preparation Technology